Optimal treatment of acute coronary syndromes - An evolving strategy.

被引:30
作者
Boden, WE [1 ]
McKay, RG [1 ]
机构
[1] Hartford Hosp, Hartford, CT 06112 USA
关键词
D O I
10.1056/NEJM200106213442510
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1939 / 1942
页数:5
相关论文
共 16 条
[1]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1488
[2]   Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy [J].
Boden, WE ;
O'Rourke, RA ;
Crawford, MH ;
Blaustein, AS ;
Deedwania, PC ;
Zoble, RG ;
Wexler, LF ;
Kleiger, RE ;
Pepine, CJ ;
Ferry, DR ;
Chow, BK ;
Lavori, PW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1785-1792
[3]  
Boden WE, 1998, NEW ENGL J MED, V339, P1091
[4]  
BRAUNWALD E, 1994, CIRCULATION, V89, P1545
[5]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[6]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[7]   Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial [J].
Herrmann, HC ;
Moliterno, DJ ;
Ohman, EM ;
Stebbins, AL ;
Bode, C ;
Betriu, A ;
Forycki, F ;
Miklin, JS ;
Bachinsky, WB ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1489-1496
[8]   Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors [J].
Lincoff, AM ;
Califf, RM ;
Moliterno, DJ ;
Ellis, SG ;
Ducas, J ;
Kramer, JH ;
Kleiman, NS ;
Cohen, EA ;
Booth, JE ;
Sapp, SK ;
Cabot, CF ;
Topol, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :319-327
[9]   Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. [J].
Montalescot, G ;
Barragan, P ;
Wittenberg, O ;
Ecollan, P ;
Elhadad, S ;
Villain, P ;
Boulenc, JM ;
Morice, MC ;
Maillard, L ;
Pansiéri, M ;
Choussat, R ;
Pinton, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1895-1903
[10]   A COMPARISON OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
SERRUYS, PW ;
DEJAEGERE, P ;
KIEMENEIJ, F ;
MACAYA, C ;
RUTSCH, W ;
HEYNDRICKX, G ;
EMANUELSSON, H ;
MARCO, J ;
LEGRAND, V ;
MATERNE, P ;
BELARDI, J ;
SIGWART, U ;
COLOMBO, A ;
GOY, JJ ;
VANDENHEUVEL, P ;
DELCAN, J ;
MOREL, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :489-495